Advanced Biomedical Technologies Stock Price Prediction
| ABMT Stock | USD 0.0001 0.00 0.00% |
Momentum 27
Sell Stretched
Oversold | Overbought |
Using Advanced Biomedical hype-based prediction, you can estimate the value of Advanced Biomedical Technologies from the perspective of Advanced Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Advanced Biomedical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Advanced because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Advanced Biomedical after-hype prediction price | USD 1.12E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Advanced |
Advanced Biomedical After-Hype Price Prediction Density Analysis
As far as predicting the price of Advanced Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Advanced Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Advanced Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Advanced Biomedical Estimiated After-Hype Price Volatility
In the context of predicting Advanced Biomedical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Advanced Biomedical's historical news coverage. Advanced Biomedical's after-hype downside and upside margins for the prediction period are 0.00 and 12.14, respectively. We have considered Advanced Biomedical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Advanced Biomedical is out of control at this time. Analysis and calculation of next after-hype price of Advanced Biomedical is based on 3 months time horizon.
Advanced Biomedical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Advanced Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Advanced Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Advanced Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.52 | 12.23 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 12.33 |
|
Advanced Biomedical Hype Timeline
Advanced Biomedical is presently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Advanced is expected to increase in value after the next headline, with the price projected to jump to 1.12E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is estimated to be 12.33%, whereas the daily expected return is presently at -0.52%. The volatility of related hype on Advanced Biomedical is about 0.0%, with the expected price after the next announcement by competition of 0.00. Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in 5 to 10 days. Check out Advanced Biomedical Basic Forecasting Models to cross-verify your projections.Advanced Biomedical Related Hype Analysis
Having access to credible news sources related to Advanced Biomedical's direct competition is more important than ever and may enhance your ability to predict Advanced Biomedical's future price movements. Getting to know how Advanced Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Advanced Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GRPS | Gold River Prods | 0.00 | 0 per month | 18.44 | 0.12 | 100.00 | (50.00) | 150.00 | |
| RMSL | REMSleep Holdings | 0.00 | 0 per month | 6.00 | (0.01) | 12.86 | (11.67) | 38.07 | |
| RMRK | Rimrock Gold Corp | 0.00 | 0 per month | 0.00 | 0.04 | 33.33 | (25.00) | 66.67 | |
| UATG | Umbra Applied Technologies | 0.00 | 0 per month | 17.80 | 0.05 | 33.33 | (28.57) | 300.00 | |
| DUTV | Digital Uts Ventures | 0.00 | 0 per month | 8.47 | 0.17 | 23.71 | (14.00) | 54.49 |
Advanced Biomedical Additional Predictive Modules
Most predictive techniques to examine Advanced price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Advanced using various technical indicators. When you analyze Advanced charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Advanced Biomedical Predictive Indicators
The successful prediction of Advanced Biomedical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Advanced Biomedical Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Advanced Biomedical based on analysis of Advanced Biomedical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Advanced Biomedical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Advanced Biomedical's related companies.
Story Coverage note for Advanced Biomedical
The number of cover stories for Advanced Biomedical depends on current market conditions and Advanced Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Advanced Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Advanced Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Advanced Biomedical Short Properties
Advanced Biomedical's future price predictability will typically decrease when Advanced Biomedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Advanced Biomedical Technologies often depends not only on the future outlook of the potential Advanced Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Advanced Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.1 M | |
| Cash And Short Term Investments | 201.7 K |
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.